User satisfaction with an intrauterine system containing 52 mg levonorgestrel: a Portuguese study

Abstract

Objective

To characterise patient satisfaction 6 and 12 months after insertion of a 52 mg levonorgestrel‐releasing intrauterine system (LNG-IUS) in Portuguese women.

Study design

A non-interventional and prospective study was conducted in Portuguese women of reproductive age who had Levosert^® inserted. Two questionnaires (administered 6 and 12 months after 52 mg LNG-IUS insertion) were used to collect information on the patients’ menstrual pattern, discontinuation rate, and satisfaction rate with Levosert^®.

Results

A total of 102 women were enrolled, of which only 94 (92.2%) completed the study. Seven participants discontinued the use of the 52 mg LNG-IUS. At 6 and 12 months, 90.7% and 90.4% of participants, respectively, were either satisfied or very satisfied with the 52 mg LNG-IUS. At 6 and 12 months, 73.2% and 72.3% of participants, respectively, indicated that they were very likely to recommend the 52 mg LNG-IUS to a friend or family member. Most women (92.2%) continued to use the 52 mg LNG-IUS for the first year. The percentage of women who were ‘much more satisfied’ with Levosert^® than with their previous contraceptive methods was 55.9% and 57.8% at 6 and 12 months, respectively, per questionnaire assessment. Satisfaction was associated with age (p = 0.004), amenorrhoea (p < 0.003) and absence of dysmenorrhoea (p = 0.003), but not with parity (p = 0.922).

Conclusions

These data suggest that the continuation and satisfaction rates with Levosert^® were very high, and that this system is well accepted among Portuguese women. Patient satisfaction was driven by a favourable bleeding pattern and absence of dysmenorrhoea.

Short Condensation

Satisfaction with the 52 mg levonorgestrel‐releasing intrauterine system was high among Portuguese women. Patient satisfaction was mainly driven by a favourable bleeding pattern and absence of dysmenorrhoea.

摘要

目的：了解葡萄牙妇女在植入52毫克左炔诺孕酮宫内缓释系统（LNG-IUS）6个月和12个月后的患者满意度。

研究设计：对植入了Levosert$\text{R}$的葡萄牙妇女进行了一项前瞻性、非干预性的研究。两份调查问卷（在植入52毫克LNG-IUS后6个月和12个月进行）用于收集患者的月经模式、停药率和对Levosert$\text{R}$的满意率等信息。

结果：共有102名女性参与了研究, 其中只有94人（92.2%）完成了研究。七名参与者停止使用52 mg LNG-IUS。在6个月和12个月时, 分别有90.7%和90.4%的参与者对52 mg LNG-IUS感到满意或非常满意。在6个月和12个月时, 分别有73.2%和72.3%的参与者表示, 他们很可能向朋友或家人推荐52 mg LNG-IUS。大多数女性（92.2%）在第一年继续使用52 mg LNG-IUS。根据问卷评估, 在 6 个月和 12 个月时, 对Levosert$\text{R}$比对以前的避孕方法“更满意”的女性比例分别为 55.9% 和 57.8%。满意度与年龄（p=0.004）、闭经（p<0.003）和无痛经（p=0.003）有关, 但与产次无关（p=0.922）。

结论：这些数据表明, Levosert$\text{R}$的持续使用率和满意率非常高, 这一系统在葡萄牙妇女中得到了广泛接受。良好的出血模式和无痛经令患者感到满意。

简短概括

葡萄牙妇女对52毫克左炔诺孕酮宫内缓释系统的满意度很高。患者的满意度主要来自于良好的出血模式和无痛经。

Keywords:

• Contraception
• intrauterine system
• satisfaction
• levonorgestrel

Disclosure statement

No potential conflict of interest was reported by the author(s).